Last reviewed · How we verify
NCT04112121: HEALING
Psychological, Neurological and Immunological Changes Following a Meeting With a Chaplain Coupled With Biblical Readings
NA trial testing Meeting with a Chaplain coupled with Biblical Readings in Hospitalism in 57 participants. Completed in 2 January 2017.
2 January 2017
Quick facts
| Lead sponsor | Somogy Megyei Kaposi Mór Teaching Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 57 |
| Start date | 10 September 2015 |
| Primary completion | 2 January 2017 |
| Estimated completion | 2 January 2017 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- Meeting with a Chaplain coupled with Biblical Readings
Conditions studied
- Hospitalism — all drugs for Hospitalism →
Sponsor
Somogy Megyei Kaposi Mór Teaching Hospital
Who can join
18 and older, any sex, with Hospitalism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the "HEALING" " (Hospital-based Ecumenical And Linguistic Immuno-NeuroloGic) Study was to examine immunological and neurological changes in hospitalized participants after meeting a chaplain and Biblical listenings, in order to evaluate whether these meetings affect the course of the disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Healing through faith: Meeting a chaplain coupled with biblical readings could produce lymphocyte changes that correlate with brain activity (HEALING study).
Béres A, Emri M, Aranyi C, Fajtai D, et al · · 2021 · PMID 40496603 · DOI 10.12688/f1000research.74504.5
Verify or expand the search:
- PubMed search for NCT04112121
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hospitalism
Currently open trials in the same condition.
- NCT06232551 — Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism · NA · recruiting
Other Somogy Megyei Kaposi Mór Teaching Hospital trials
Trials by the same sponsor.
- NCT07333222 — Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis · NA · recruiting
- NCT07411664 — Assessment of Trunk Control and Postural Instability in Patients With Various Neurological Disorders (Stroke, Parkinson, · NA · enrolling by invitation
- NCT07350798 — Applicability of Robotic Devices, Virtual and Augmented Reality in the Rehabilitation of People With Stroke During Tread · NA · recruiting
- NCT07352085 — Exoskeleton-assisted Neurorehabilitation · NA · completed
- NCT05947773 — Effect of Robotic Treatments on Motor Functions in Subacute Stroke Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04112121 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Somogy Megyei Kaposi Mór Teaching Hospital
- Last refreshed: 15 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04112121.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing